Human Genome Epidemiology Literature Finder
Records 1 - 17 (of 17 Records) |
Query Trace: Epilepsy and EPHX1[original query] |
---|
Genetic variants in microsomal epoxide hydrolase influence carbamazepine dosing. Clinical neuropharmacology 0 32 (4): 205-12. Makmor-Bakry Mohd, Sills Graeme J, Hitiris Nikolas, Butler Elaine, Wilson Elaine A, Brodie Martin |
Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations. Pharmacogenetics and genomics 2010 Jan 20 (1): 58-63. Azzato Elizabeth M, Chen Renee A, Wacholder Sholom, Chanock Stephen J, Klebanoff Mark A, Caporaso Neil |
Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment. Pharmacogenomics 2010 Jul 11 (7): 927-41. Grover Sandeep, Gourie-Devi Mandaville, Baghel Ruchi, Sharma Sangeeta, Bala Kiran, Gupta Meena, Narayanasamy Krishnamoorthy, Varma Binuja, Gupta Meenal, Kaur Kavita, Talwar Puneet, Kaur Harpreet, Giddaluru Sudheer, Sharma Abhay, Brahmachari Samir K, Indian Genome Variation Consortium , Kukreti Ritushr |
Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. Pharmacogenomics 2013 Jan 14 (1): 1. Puranik YG, Birnbaum AK, Marino SE, Ahmed G, Cloyd JC, Remmel RP, Leppik IE, Lamba JK |
Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. Epilepsy research 2013 Dec 107 (3): 231-7. Yun Wenting, Zhang Feng, Hu Cheng, Luo Xiaopei, Xue Peng, Wang Jing, Ge Yubin, Meng Hongmei, Guo Yingj |
Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy. Epilepsia 2014 Aug 55 (8): 1301-6. He Xiao-Jing, Jian Ling-Yan, He Xiao-Lin, Tang Man, Wu Yan, Xu Yuan-Yuan, Sun Xiao-Jie, Zhao Li-M |
Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy. Pharmacogenomics 2014 15 (15): 1867-79. Zhu Xu, Yun Wenting, Sun Xiaofu, Qiu Feng, Zhao Limei, Guo Yingj |
Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients. PloS one 2015 10 (11): e0142408. Daci Armond, Beretta Giangiacomo, Vllasaliu Driton, Shala Aida, Govori Valbona, Norata Giuseppe Danilo, Krasniqi Sha |
Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients. Journal of neurogenetics 2016 03 30 (1): 16-21. Chbili Chahra, Fathallah Neila, Laouani Aicha, Nouira Manel, Hassine Anis, Ben Amor Sana, Ben Ammou Sofiene, Ben Salem Chaker, Saguem Sa |
Allele and genotype frequencies of genes relevant to anti-epileptic drug therapy in Mexican-Mestizo healthy volunteers. Pharmacogenomics 2016 Oct . Fricke-Galindo Ingrid, Ortega-Vázquez Alberto, Monroy-Jaramillo Nancy, Dorado Pedro, Jung-Cook Helgi, Peñas-Lledó Eva, LLerena Adrián, López-López Maris |
Association between EPHX1 polymorphisms and carbamazepine metabolism in epilepsy: a meta-analysis. International journal of clinical pharmacy 2019 10 41 (6): 1414-1428. Zhao Gui-Xin, Shen Ming-Li, Zhang Zheng, Wang Ping, Xie Chun-Xiang, He Gong-H |
Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine. British journal of clinical pharmacology 2020 Nov . Yip Vincent L M, Pertinez Henry, Meng Xiaoli, Maggs James L, Carr Daniel F, Park B Kevin, Marson Anthony G, Pirmohamed Mun |
ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients. Gene 2021 8 805 145907. Zhang Ming-Liang, Chen Xiao-Long, Bai Zhao-Fang, Zhao Xu, Li Wei-Xia, Wang Xiao-Yan, Zhang Hui, Chen Xiao-Fei, Zhang Shu-Qi, Tang Jin-Fa, Xiao Xiao-He, Zhao Yan-Li |
Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital. Pharmacogenomics 2021 10 22 (15): 983-996. Fricke-Galindo Ingrid, Jung-Cook Helgi, Martínez-Juárez Iris E, Monroy-Jaramillo Nancy, Ortega-Vázquez Alberto, Rojas-Tomé Irma S, Dorado Pedro, Peñas-Lledó Eva, Llerena Adrián, López-López Maris |
Genetic polymorphisms of microsomal epoxide hydrolase and UDP-glucuronosyltransferase (UGT) and its effects on plasma carbamazepine levels and metabolic ratio in persons with epilepsy of South India: A cross-sectional genetic association study. Indian journal of pharmacology 2023 8 55 (3): 149-154. Shravan Venkatraman, Kesavan Ramasamy, Pradeep Pankajakshan Na |
Influence of EPHX1 c.337 T>C and UGT2B7*2 genetic polymorphisms on the requirement of carbamazepine maintenance dose in person with epilepsy (PWE) of Southern part of India: a cross-sectional genetic association study. Drug metabolism and personalized therapy 2023 2 . Venkatraman Shravan, Ramasamy Kesavan, Nair Pradeep P, Rajendran Priyadharsi |
A real-life pilot study of the clinical application of pharmacogenomics testing on saliva in epilepsy. Epilepsia open 2023 2 . Riva Antonella, Roberti Roberta, D'Onofrio Gianluca, Stella Vari Maria, Amadori Elisabetta, De Giorgis Valentina, Cerminara Caterina, Specchio Nicola, Pietrafusa Nicola, Tombini Mario, Assenza Giovanni, Cappanera Silvia, Marini Carla, Rasmini Paolo, Veggiotti Pierangelo, Zara Federico, Russo Emilio, Striano Pasqua |
- Page last reviewed:Feb 1, 2024
- Page last updated:Jun 11, 2024
- Content source: